About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, May 8th, 2014

The QualityStocks
Daily Stock List


Terme Bancorp, Inc. (TMEB)

Today we are highlighting Terme Bancorp, Inc. (TMEB), as "One to Watch," here at the QualityStocks Daily Newsletter.

Terme Bancorp, a holding company focused on the booming global electronic money services space, as well as the relevant associated behavioral dynamics among consumers, operates through a growing family of wholly owned subsidiaries, each with a distinct target market. Beyond the company's Terme Capital, Inc. subsidiary, whose foundations stretch back to the company's 1987 acquisition/operation of Argo Federal Savings and Loan Association from FSLIC, as well the purchase in 1995 of OnLine Financial Services (thus establishing one of the very first internet branch operations on earth), there is the Terme Mortgage, Inc. subsidiary, an established mortgage services operation.

The company has a solid track record of achievements under its belt and the feat of establishing a successful branch on the West Side of Chicago (where there hadn't been one in 35 years), as well as the successful deployment of ATMs throughout the inner city, really reinforces TMEB's philanthropic commitment to serving populations like the unbanked and under-banked, in this case with comprehensive financial services. The company used their muscle and ingenuity, taking point on the mission to foster an electronic debit card framework for the area and the results were superb, with government assistance payment streamlining and leveraging of a social services agency, to bring much needed jobs to ex-offenders and the like, helping to simultaneously offset the ongoing housing crisis for the local market.

This same dauntless, charitable attitude by TMEB has led to the formation of a new wholly owned subsidiary, Terme Medical Ventures, Inc., which will be tasked with hammering out quality investments in a variety of consumer-oriented medical vectors. The three primary initial targets for this new subsidiary will be the lucrative and rapidly expanding medical marijuana market, as well as the clinical device and infectious disease treatment markets. Terme Medical Ventures will emphasize refining an ability to provide the best in cutting-edge growing and distribution technologies, as well as related services, in addition to aligning key affinity relationships and partnerships in what is now a rapidly burgeoning industry.

Nationally speaking, the legal market for the broadest category of  marijuana sales was around $1.53B in 2013, a figure expected to climb 422% to a whopping $8B by 2018 alone (with the ArcView report placing the figure substantially higher at $10.2B). Company plans to do some serious damage in the thriving device space will be bolstered by important relationships that management has already established in the space. TMEB will be fast out of the gate developing or licensing clinical device technology that will let users not only do over watch on their own health with robust monitoring, but also improve their health at the same time. Infectious disease is a good third leg here and the overlap should be apparent to anyone following the sector closely.

The prevailing marijuana legislation basically says it all, with cancer, glaucoma, and HIV/AIDS at the top of the list for conditions associated with legal permitting in Colorado for instance. Major secondaries in muscle spasm, seizure, severe pain, severe nausea, and even severe weight loss/muscle atrophy (cachexia), merely cement the longer-term upside for infectious disease applications. The Charlotte's Web strain used by the parents of Charlotte Figi to treat her epileptic seizures has really galvanized this nascent industry and it is quiet easy to see the vast potential for therapeutic applications across the broader market, especially when executed in conjunction with the right kinds of health monitoring technologies.

Terme Bancorp, Inc. (TMEB), closed Thursday's trading session at $0.103, down 20.77%, on 290,972 volume with 74 trades. The average volume for the last 60 days is 20,555 and the stock's 52-week low/high is $0.014/$0.30.

Protea Biosciences Group, Inc. (PRGB)

Today we are highlighting Protea Biosciences Group, Inc. (PRGB), here at the QualityStocks Daily Newsletter.

Founded in 2001, Protea Biosciences Group, Inc. is a molecular information company based in Morgantown, West Virginia. Its proprietary technology enables direct molecular imaging, which is the ability to identify and display biomolecules in tissue and cells, without sample pre-treatment. The Company delivers strong molecular information to medical and life science researchers globally. Protea Biosciences Group’s stock commenced trading on the OTCQB marketplace of the OTC Markets Group, Inc. under the ticker symbol PRGB on April 14, 2014.

The Company concentrates on meeting the needs of the pharmaceutical, biotechnology, agriculture, chemical and other industries with innovative technologies, software, as well as services. It maintains its own laboratory facility. There, it performs services using (Laser Ablation Electrospray Ionization) LAESI® and complementary technologies for a broad assortment of customers to support preclinical pharmaceutical research and development (R&D), biomarker discovery, and other applications. In addition, Protea collaborates with researchers to apply its technologies and expertise to generate new discoveries and intellectual property (IP).

The Company’s proprietary technology, LAESI®, is used with mass spectrometry to detect the presence of up to, and over, 1,000 distinct molecules from a single analysis of samples, which can include tissues, cells, fluids, agricultural specimens and other sample types. Using proprietary software (ProteaPlot™), the location of each distinct molecule in a respective sample can be displayed. This allows for direct molecular imaging. The LAESI DP-1000 is marketed to a broad spectrum of researchers for many applications. The LAESI DP-1000 is an integrated system that combines LAESI and ProteaPlot™.

Last week, Protea Biosciences Group announced it has started a collaborative research initiative with the Memorial Sloan-Kettering Cancer Center (MSK) and the Dana-Farber Cancer Institute (Dana-Farber) that uses the Company’s next generation LAESI direct molecular imaging technology to analyze cancer cells. The initial focus is early stage lung adenocarcinoma. The studies will employ LAESI technology to generate molecular data profiles of cancer cells in tissue and biofluids to improve the understanding of a cancer's origin.

Protea Biosciences Group, Inc. (PRGB), closed Thursday's trading session at $2.18, down 0.91%, on 2,550 volume with 9 trades. The average volume for the last 60 days is 2,312 and the stock's 52-week low/high is $0.91/$5.00.

Mountain High Acquisitions Corp. (MYHI)

Charms Investment LTD, FivedollarMovers.net, Integrity Solution IR, Wallstreet Profiler, and PennyDoctor reported recently on Mountain High Acquisitions Corp. (MYHI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mountain High Acquisitions Corp. is a strategic real estate holding company headquartered in Denver, Colorado. Its principal focus is the acquisition and development of commercial properties in the marijuana sector. At present, the Company’s portfolio includes three Colorado properties zoned for commercial marijuana cultivation: Isabelle, Madison, and Pueblo. Mountain High Acquisitions’ shares trade on the OTC Markets’ OTCQB.

The Company’s focus is to serve the marijuana industry as a landlord providing value-added, state-of-the-art facilities and services. It does not and will not grow, harvest, distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act. It does not intend to do so in the future.

Mountain High Acquisitions’ tenants are licensed growers. The State of Colorado limits the number of commercial marijuana growers’ licenses. Therefore, the market of available tenants is tightly controlled and well understood. Currently, the Company believes existing demand from the licensed growers with whom it is in contact is more than adequate to fill any vacancy on its properties.

Mountain High Acquisitions, by way of its wholly-owned subsidiary, Canna-Life Corp., is the current holder of purchase options on the three above-named real estate properties zoned by the State of Colorado and municipal authorities for the cultivation of marijuana.

Last week, Mountain High Acquisitions reported that the March 2014 harvest completed by the licensed marijuana grower at the Isabelle Property in Colorado yielded 430 lbs. flower and more than 201 lbs. of trim/shake to undergo processing into oil extractions and other infused products. The record harvest volume at Isabelle represents an approximate 430 percent increase over the March 2013 harvest of 119 lbs.

This week, Mountain High Acquisitions announced that Canna-Life completed the definitive Master Property Purchase and Sale Agreement for the acquisition of three properties and improvements located in Lafayette, Boulder County, Colorado, referred to as the Isabelle Property; Avondale, Pueblo County, Colorado, referred to as the Pueblo Property; and Denver, Denver County, Colorado, referred to as the Madison St. Property.

Mountain High Acquisitions Corp. (MYHI), closed Thursday's trading session at $3.80, up 2.70%, on 4,411 volume with 20 trades. The average volume for the last 60 days is 15,901 and the stock's 52-week low/high is $1.00/$15.00.

Liberated Energy, Inc. (LIBE)

PennyStocks24, Top Stock Tips, TheMicrocapNews, WiseAlerts, Information Solutions Group, and Real Pennies reported on Liberated Energy, Inc. (LIBE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Liberated Energy, Inc. is a growing alternative energy company that lists on the OTC Bulletin Board. It looks to reduce the purging of the planet's resources through bringing patentable and affordable ideas to the market. The Company’s first goal is to make small wind and solar turbine technology a significant contributor to the worldwide clean energy supply portfolio. This is by providing consumers with an affordable renewable energy option for their homes and businesses.

This past March, Liberated Energy announced that via a partnership with Hemp, Inc. (HEMP), it will be expanding its alternative energy technologies into the industrial hemp industry. By working in tandem, Hemp and its subsidiaries will be able to provide new gateways of distribution for Liberated Energy's unique Guard Lite™ Security Lighting System and its other patent pending technologies.

After entering into an agreement with Hemp’s “The Industrial Hemp and Medical Marijuana Consulting Company, Inc. “(IHMMCC) to help Liberated Energy market and distribute its alternative energy products in the Industrial Hemp and Medical Marijuana industries, IHMMCC facilitated the largest order, so far, for Liberated Energy’s Guard Lite™ Security Lighting System, less than one week after its strategic partnership. The order was for 20 lighting units which created revenue for Liberated Energy.

This week, Hemp publicized the signing of Senate Bill 2175 (Act 56) by Hawaii Governor, Neil Abercrombie to allow the state's University of Hawaii, College of Tropical Agriculture and Human Resources (at Manoa) to establish a two-year industrial hemp remediation and biofuel crop research and analysis program. According to the Bill, the higher institution can now safely grow and cultivate Hemp for a research analysis program that not only the State of Hawaii could significantly benefit from. The Bill aligns with the 2014 Farm Bill emplaced by President Obama.

So far, 33 states and Puerto Rico have introduced pro-hemp legislation. Now, with Hawaii, 23 states have already passed pro-hemp legislation. 

Liberated Energy, Inc. (LIBE), closed Thursday's trading session at $0.0936, up 33.71%, on 547,988 volume with 46 trades. The average volume for the last 60 days is 179,290 and the stock's 52-week low/high is $0.0211/$1.10.

Cross Border Resources, Inc. (XBOR)

RedChip, FeedBlitz, and SmallCapVoice reported previously on Cross Border Resources, Inc. (XBOR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cross Border Resources, Inc. is an oil and gas exploration company whose shares trade on the OTC Markets’ OTCQB. The Company holds more than 868,000 gross (approximately 295,000 net) mineral and lease acres, situated mainly in New Mexico. Cross Border Resources is based in Dallas, Texas and 99 percent of its acreage consists of either owned mineral rights or leases held by production. The Company launched in January of 2011. This was following the combination of Doral Energy Corp. and Pure Energy Group. As of December 9, 2013, Red Mountain Resources, Inc. owns approximately 81 percent of Cross Border Resources’ outstanding common stock.

Cross Border Resources’ present operations focus on the prolific, multi-play/multi-pay Permian Basin. The Company is working to become the premier, non-operated working interest owner in the Permian's fast emerging, unconventional plays. This is in addition to participating in the basin's well-established, conventional plays. Approximately 26,000 of its net acres sit within the Permian Basin.

Present development of Cross Border Resources’ acreage is centered on its prospective Bone Spring acreage situated in the heart of the 1st and 2nd Bone Spring play. This play covers roughly 4,390 square miles across New Mexico and Texas. The Company currently owns varying, non-operated working interest in Eddy and Lea counties, New Mexico, along with its working interest (WI) partners, which include Cimarex, Apache, and Mewbourne. These all have important footprints within this play.
Additional development is currently taking place on Cross Border Resources’ Abo, Yeso, as well as San Andres acreage with its other WI partners.

In the first half of fiscal 2013, the Company completed 15 gross wells (1.40 net). These included 6 horizontal Bone Spring wells (0.91 net), 2 horizontal Yeso wells (0.11 net), 6 vertical Glorieta-Yeso wells (0.32 net), and 1 vertical Queen-Grayburg-San Andres well (0.06 net). On June 30, 2013, there were 2 wells (0.06 net) drilled and awaiting completions. Both of these are vertical Glorieta-Yeso wells.

In addition, the Company reported in December 2013 that its planned operations also include drilling and completing wells, re-entering and completing wells, or improving infrastructure. Its main area of focus is the Tom Tom/Tomahawk Prospect. This is where it will work on the field alongside the execution of its remediation plan. For fiscal 2013, this included the re-entry of 14 gross wells (11.7 net), the drilling of 6 gross wells (5.2 net), and the improvement of field infrastructure.

The Company said it would also spend capital in a number of non-operated prospect areas. At present, its commitment is to participating in the drilling of 3 gross wells (0.3 net). It expected to receive more well proposals before the end of fiscal 2013.

Cross Border Resources, Inc. (XBOR), closed Thursday's trading session at $1.53, down 8.38%, on 13,036 volume with 22 trades. The average volume for the last 60 days is 11,351 and the stock's 52-week low/high is $0.25/$1.85.


The QualityStocks
Company Corner


Infinite Group, Inc. (IMCI)

The QualityStocks Daily Newsletter would like to spotlight Infinite Group, Inc. (IMCI). Today, Infinite Group, Inc. closed trading at $0.075, even for the day, on 4,100 volume with 3 trades. The stock’s average daily volume over the past 60 days is 7,867, and its 52-week low/high is $0.05/$0.20.

Infinite Group, Inc. announced today that it has completed a partner agreement with Unitrends, a fast-rising provider in the IT protection and disaster recovery industry. With this business relationship, IGI offers Unitrends' unified solution portfolio of multi-environment backup, archiving, and disaster recovery technology that lets customers play IT safe, anytime, anywhere by protecting and preserving their physical, virtual, and cloud environments at the lowest possible total cost of ownership.

Infinite Group, Inc. (IMCI) professionals plan, integrate, manage and support complete IT solutions for customers in small to medium-sized businesses, government agencies and large commercial enterprises. Dedicated to quality and customer service, the company’s team of over 80 IT specialists is experienced in their individual fields and maintains the latest certifications. Infinite Group also partners with industry leaders such as VMware, HP, Microsoft, Cisco, and Dell to ensure its customers receive the best combination of products and services designed for their specific needs.

The company’s scalable solutions cover the entire IT chain, including consulting and project management, data storage and recovery solutions, IT security, managed services, and complete IT system development. Providing customers a single point of contact for all their IT needs, Infinite Group helps companies focus on their core business by improving IT efficiencies, reducing capital expenditures, and enjoying significant savings on operational costs.

Based in the Rochester, New York area, the company leverages its deep roots in technology to be one of today’s premier IT service and support suppliers. The company’s IT professionals provide on-site support to customers around the world and serve some of the premiere businesses and government organizations in the United States and worldwide including the U.S. Post Office, PepsiCo, Inc., the State of Mississippi, Home Depot, NASA, Pricewaterhouse Coopers, the Florida Department of Financial Services, the U.S. Air Force, Navy, Army, and others. Personnel are located throughout the U.S. including Colorado Springs, Springfield and Vienna, Virginia and Washington, D.C. for added government support.

The IT services industry generates $500 billion in annual revenues and continues to grow as businesses progressively rely on technology to maintain operations and increase efficiency. With decades of experience and technical knowledge, and guided by the highest governance and business conduct guidelines, Infinite Group’s leadership team meets current and future business demands with expertise and effectiveness. Disclaimer

Infinite Group, Inc.Company Blog

Infinite Group, Inc.News:

Infinite Group, Inc. Partners With Unitrends to Provide Data Protection

Cybersecurity on Infinite Group, Inc.'s Radar With New Hire

Infinite Group, Inc. CEO Featured in Exclusive QualityStocks Interview

Great Plains Holding, Inc. (GTPH)

The QualityStocks Daily Newsletter would like to spotlight Great Plains Holding, Inc. (GTPH). Today, Great Plains Holding, Inc. closed trading at $1.25, even for the day, on 100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 110, and its 52-week low/high is $0.75/$2.00.

Great Plains Holdings, Inc. today announced that a new audio interview with Great Plains Holdings, Inc. president, director and Chief Operating Officer Denis Espinoza is now available. The interview can be heard at http://www.qualitystocks.net/interview-gtph.php.

Great Plains Holding, Inc. (GTPH) operates through two wholly owned subsidiaries: Ashland Holdings, LLC, focused on the real estate sector; and LiL Marc, Inc., maker of the "LiL Marc" training urinal for toddler boys. This diversification model enables Great Plains to achieve multiple revenue streams and consistently increase hard assets.

Ashland Holdings, LLC is engaged in the acquisition and operation of commercial real estate, including, but not limited to, self-storage facilities, apartment buildings, manufactured housing communities for senior citizens, and other income-producing properties. The subsidiary’s current portfolio includes a 1,400-square-foot corporate office building; an 800-square-foot warehouse for LiL Marc operations; and two adjacent parcels of land, one of which includes a manufactured home that is rented out for additional income. Ashland and LiL Marc plan to occupy one or more of the five office spaces located in the corporate office building to accommodate expected expansion. The remaining vacant offices may be leased to tenants to create a source of revenue.

LiL Marc, Inc. is Great Plains’ principal business activity. Founded in 1999, the subsidiary engages in the manufacturing and marketing of training urinals for boys in the United States. The LiL Marc boys potty training urinal looks like the full sized urinals found in public restrooms, but are manufactured on a smaller scale in proportion to the smaller size of toddlers in training. In conjunction with the roll-out of an aggressive marketing campaign for the LiL Marc product, Great Plains’ management team is building a client list of retailers with brick and mortar stores and other consumer outlets to participate in the broader retail market. With advertising strategies in place, management envisions growth and widespread distribution of the LiL Marc training urinal.

Great Plains also intends to purchase privately-owned profitable businesses owned by baby boomers looking to retire. As the company continues to execute its expansion strategy and add additional subsidiaries, all potential purchases will be reviewed by management to ensure they meet very stringent requirements. Disclaimer

Great Plains Holding, Inc. Company Blog

Great Plains Holding, Inc. News:

Great Plains Holdings, Inc. President, COO Featured in Exclusive QualityStocks Interview

Great Plains Holdings, Inc. Completes Final Phase of Real Estate Asset Project Ahead of Schedule

Great Plains Holdings, Inc. Partners With TexStar Energy for Texas Lease With Nearly 3M Barrels of Estimated Oil Reserves

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.155, off by 1.59%, on 430,619 volume with 88 trades. The stock’s average daily volume over the past 60 days is 580,852, and its 52-week low/high is $0.13/$0.34.

International Stem Cell Corp. announced today that it will host a conference call on Wednesday, May 14, 2014 to provide a business update and discuss its financial results for the three months ended March 31, 2014. Dr. Simon Craw, Executive Vice President and Mr. Jay Novak, Chief Financial Officer of International Stem Cell will host the conference call. Date: Wednesday, May 14, 2014, Time: 11:00 a.m. Eastern Time, Conference Number (U.S.): 1-877-941-2069, International Dial-In: 1-480-629-9713, Conference ID: 4682485. Webcast: http://public.viavid.com/confirmation/confirmwebcast.php?id=o5aroJyX

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation to Host First Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Wednesday, May 14, 2014

International Stem Cell Corporation Announces Positive Parkinson's Disease Data

International Stem Cell Corporation to Provide an Update on Its Parkinson's Disease Program at the 66th American Academy of Neurology Annual Meeting

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.60, off by 1.64%, on 5,625 volume with 7 trades. The stock’s average daily volume over the past 60 days is 15,969, and its 52-week low/high is $0.50/$1.00.

Zenosense, Inc. was pleased to announce today that the Company has extended its agreement with the Sgenia Group to include cancer sensory devices. Under the terms of the extension, Zenosense has the optional right to fund the development of prospective cancer sensory devices that may be based on the Sgenia technology. Subject to providing funding, the Company will have the right to manufacture, market and sell the resulting devices(s), if developed.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. Extends License to Include Cancer Applications

Zenosense, Inc. Enters Into $475,000 Securities Purchase Agreement

Zenosense, Inc. Launches New Company Website

Victory Energy Corp. (VYEY)

The QualityStocks Daily Newsletter would like to spotlight Victory Energy Corp. (VYEY). Today, Victory Energy Corp. closed trading at $0.35, even for the day, on 7,444 volume with 5 trades. The stock’s average daily volume over the past 60 days is 6,200, and its 52-week low/high is $0.0136/$0.51.

Victory Energy Corp. today announced that it has agreed to purchase a 10% non-operated Working Interest ownership of "The Fairway Prospect" from a wholly-owned subsidiary of Target Energy Limited (ASX: TEX) (OTCQX: TEXQY) for a total cash consideration of approximately $6.0 million. Also ion the news today for VYEY, the company was peladed to announce that they have been approved to trade on OTCQX®, the best marketplace with qualified companies.

Victory Energy Corp. (VYEY) is an independent, growth-oriented oil and gas company focused on growing proved reserves and cash-flow via the continued development of existing properties and the acquisition of new resource properties, primary located in the prolific Permian Basin of Texas and southeast New Mexico. The Company will source new capital to facilitate this growth by continuing to utilize an established pipeline of investors available through Aurora Energy Partners and additional third-party sources. The company is committed to creating long-term shareholder value by increasing oil reserves, lowering costs, boosting production volumes, and prudently managing the capital on its balance sheet.

The company is geographically focused onshore, with a primary emphasis on the Permian Basin of Texas and southeast New Mexico. Victory strategically utilizes both internal capabilities and strategic industry relationships to acquire non-operated working interest positions in low-to-moderate risk oil and gas prospects. Its focus is on oil or liquid-rich gas projects within longer-life reservoirs that offer competitive finding and development (F&D) costs per barrel of oil equivalent (BOE).

Victory’s carefully assembled management team has more than 120 years of direct and relevant oil and gas experience. The company also utilizes a team of third-party professionals on an as-needed basis. This team includes geologists for property evaluation and assessment and reservoir engineering resources for the analysis of current and new properties. Reserve reporting is performed by a third-party engineer located in Midland, Texas. Each independent operator utilized by the company also has their own array of experts.

As it executes its strategy, Victory will be targeting investment in larger working interest projects (10%-25% that are weighted toward oil and high-BTU natural gas. This approach of increasing economic interest should allow for improved returns through cost efficiencies derived from economies of scale. Lower expenses and additional capital will give the company added flexibility to invest in the development of its current proven undeveloped, possible, and probable reserves, while also allowing for additional oil and gas prospects and improved working interest positions. Disclaimer

Victory Energy Corp. Company Blog

Victory Energy Corp. News:

Victory Energy Announces Acquisition of Fairway Project in West Texas

Victory Energy Begins Trading On OTCQX®

Victory Energy to Host First Quarter 2014 Earnings and Operational Update Call


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Bull Trends


Pumps and Dumps

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251